Characterization of Anthrax Lethal Toxin

炭疽致命毒素的表征

基本信息

  • 批准号:
    7796879
  • 负责人:
  • 金额:
    $ 25.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-04-01 至 2012-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The overall objective of this application is to elucidate mechanisms by which anthrax lethal toxin contributes to the disease process. Lethal toxin is an essential virulence factor that allows Bacillus anthracis to colonize and kill the host. Furthermore, damage caused by lethal toxin is likely a contributing factor to the long-term pathologies displayed by surviving patients. It is critical, therefore, to gain a better understanding of how the toxin interacts with the host. Lethal factor is the enzymatic component of the toxin that cleaves mitogen activated protein kinase kinases after being delivered to the mammalian cell cytosol by the second toxin component, protective antigen. How lethal factor's enzymatic activity causes the cellular effects associated with the toxin is poorly understood. The first aim of this proposal is to determine how lethal toxin interferes with cvtokine expression. We have discovered that lethal toxin destabilizes interleukin-8 mRNA in primary human endothelial cells. It has been shown that many transcripts are post-transcriptionally regulated by specific elements in their 3' untranslated regions and by the proteins that bind these regions. We will identify regulatory proteins and mRNA elements that are targeted by lethal toxin action; and identify other transcripts that are destabilized by the toxin. Our second aim is to determine how and why lethal toxin induces caspase-independent programmed cell death in human macrophages, but not in the immature monocvtes from which they were derived. We will use a combination of cellular fractionation and immunofluorescence techniques to identify proteins that mediate cell death; and compare toxin-sensitive and resistant cells to determine cellular properties that confer susceptibility to lethal toxin. Our final aim is to isolate lethal factor mutants that can cleave some of its substrates, but not others, so that the contributions of individual substrates to pathogenic processes can be assessed. To accomplish this, we will screen random lethal factor mutants for ones that are able to kill some cell types, but not others. This work will potentially identify new substrate binding determinants that could be targeted by therapeutics. Relevance: The goal of our research is to understand how anthrax lethal toxin damages human cells. A better understanding of how the toxin works will help doctors treat patients with anthrax and help researchers discover new drug treatments.
描述(由申请人提供):本申请的总体目标是阐明炭疽致死毒素导致疾病过程的机制。致命毒素是炭疽杆菌定殖并杀死宿主的重要毒力因子。此外,致命毒素造成的损害可能是导致幸存患者出现长期病变的一个因素。因此,更好地了解毒素如何与宿主相互作用至关重要。致死因子是毒素的酶促成分,在被第二种毒素成分(保护性抗原)递送到哺乳动物细胞胞浆后,裂解丝裂原激活的蛋白激酶激酶。致死因子的酶活性如何引起与毒素相关的细胞效应尚不清楚。该提案的首要目的是确定致命毒素如何干扰细胞因子的表达。我们发现致命毒素会破坏原代人内皮细胞中白细胞介素 8 mRNA 的稳定性。已经表明,许多转录物受到其3'非翻译区中的特定元件以及结合这些区域的蛋白质的转录后调节。我们将鉴定致命毒素作用所针对的调节蛋白和 mRNA 元件;并识别其他因毒素而不稳定的转录本。我们的第二个目标是确定致命毒素如何以及为何在人类巨噬细胞中诱导不依赖半胱天冬酶的程序性细胞死亡,但在其来源的未成熟单核细胞中则不然。我们将结合使用细胞分级分离和免疫荧光技术来鉴定介导细胞死亡的蛋白质;并比较毒素敏感细胞和耐药细胞,以确定对致命毒素易感性的细胞特性。我们的最终目标是分离出可以裂解其某些底物但不能裂解其他底物的致死因子突变体,以便可以评估单个底物对致病过程的贡献。为了实现这一目标,我们将随机筛选致死因子突变体,寻找能够杀死某些细胞类型但不能杀死其他细胞类型的突变体。这项工作将有可能确定新的底物结合决定因素,这些决定因素可以作为治疗的目标。 相关性:我们研究的目标是了解炭疽致命毒素如何损害人体细胞。更好地了解这种毒素的作用原理将有助于医生治疗炭疽患者,并帮助研究人员发现新的药物治疗方法。

项目成果

期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Distinct regions of NLRP1B are required to respond to anthrax lethal toxin and metabolic inhibition.
NLRP1B 的不同区域需要对炭疽致死毒素和代谢抑制作出反应。
  • DOI:
    10.1128/iai.02167-14
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Neiman-Zenevich,Jana;Liao,Kuo-Chieh;Mogridge,Jeremy
  • 通讯作者:
    Mogridge,Jeremy
A protective antigen mutation increases the pH threshold of anthrax toxin receptor 2-mediated pore formation.
  • DOI:
    10.1021/bi5000756
  • 发表时间:
    2014-04-08
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Dennis MK;Mogridge J
  • 通讯作者:
    Mogridge J
An anthrax lethal factor mutant that is defective at causing pyroptosis retains proapoptotic activity.
  • DOI:
    10.1111/j.1742-4658.2009.07458.x
  • 发表时间:
    2010-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ngai S;Batty S;Liao KC;Mogridge J
  • 通讯作者:
    Mogridge J
Inhibition of anthrax lethal toxin-induced cytolysis of RAW264.7 cells by celastrol.
  • DOI:
    10.1371/journal.pone.0001421
  • 发表时间:
    2008-01-09
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Chapelsky S;Batty S;Frost M;Mogridge J
  • 通讯作者:
    Mogridge J
Anthrax lethal toxin promotes dephosphorylation of TTP and formation of processing bodies.
  • DOI:
    10.1111/j.1462-5822.2009.01418.x
  • 发表时间:
    2010-04-01
  • 期刊:
  • 影响因子:
    3.4
  • 作者:
    Chow EM;Batty S;Mogridge J
  • 通讯作者:
    Mogridge J
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JEREMY S MOGRIDGE其他文献

JEREMY S MOGRIDGE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JEREMY S MOGRIDGE', 18)}}的其他基金

Characterization of Anthrax Lethal Toxin
炭疽致命毒素的表征
  • 批准号:
    7379958
  • 财政年份:
    2006
  • 资助金额:
    $ 25.46万
  • 项目类别:
Characterization of Anthrax Lethal Toxin
炭疽致命毒素的表征
  • 批准号:
    7021029
  • 财政年份:
    2006
  • 资助金额:
    $ 25.46万
  • 项目类别:
Characterization of Anthrax Lethal Toxin
炭疽致命毒素的表征
  • 批准号:
    7345645
  • 财政年份:
    2006
  • 资助金额:
    $ 25.46万
  • 项目类别:
Characterization of Anthrax Lethal Toxin
炭疽致命毒素的表征
  • 批准号:
    7598962
  • 财政年份:
    2006
  • 资助金额:
    $ 25.46万
  • 项目类别:
Development and testing of anthrax toxin inhibitors
炭疽毒素抑制剂的开发和测试
  • 批准号:
    7046921
  • 财政年份:
    2003
  • 资助金额:
    $ 25.46万
  • 项目类别:
Development and testing of anthrax toxin inhibitors
炭疽毒素抑制剂的开发和测试
  • 批准号:
    6874924
  • 财政年份:
    2003
  • 资助金额:
    $ 25.46万
  • 项目类别:
Development and testing of polyvalent anthrax toxin inhibitors
多价炭疽毒素抑制剂的开发和测试
  • 批准号:
    7455423
  • 财政年份:
    2003
  • 资助金额:
    $ 25.46万
  • 项目类别:
Development and testing of polyvalent anthrax toxin inhibitors
多价炭疽毒素抑制剂的开发和测试
  • 批准号:
    7936885
  • 财政年份:
    2003
  • 资助金额:
    $ 25.46万
  • 项目类别:
Development and testing of anthrax toxin inhibitors
炭疽毒素抑制剂的开发和测试
  • 批准号:
    6806450
  • 财政年份:
    2003
  • 资助金额:
    $ 25.46万
  • 项目类别:
Development and testing of anthrax toxin inhibitors
炭疽毒素抑制剂的开发和测试
  • 批准号:
    7215686
  • 财政年份:
    2003
  • 资助金额:
    $ 25.46万
  • 项目类别:

相似海外基金

Regulation of RNA sensing and viral restriction by RNA structures
RNA 结构对 RNA 传感和病毒限制的调节
  • 批准号:
    10667802
  • 财政年份:
    2023
  • 资助金额:
    $ 25.46万
  • 项目类别:
A germline- and promoter-independent strategy to gain access to all cell types in the brain
一种独立于种系和启动子的策略,可获取大脑中所有细胞类型
  • 批准号:
    10651435
  • 财政年份:
    2023
  • 资助金额:
    $ 25.46万
  • 项目类别:
Biogenesis of mRNA-derived telomerase long noncoding RNA
mRNA 衍生端粒酶长非编码 RNA 的生物发生
  • 批准号:
    10638429
  • 财政年份:
    2023
  • 资助金额:
    $ 25.46万
  • 项目类别:
miR-137 Regulation of Intrinsic Excitability
miR-137 内在兴奋性的调节
  • 批准号:
    10719579
  • 财政年份:
    2023
  • 资助金额:
    $ 25.46万
  • 项目类别:
Role of human apolipoprotein E isoforms in long-term effects of West Nile Virus exposure on Alzheimer's disease-related behavioral alteration, cognitive injury, neuroinflammation, and neuropathology
人类载脂蛋白 E 同工型在西尼罗河病毒暴露对阿尔茨海默病相关行为改变、认知损伤、神经炎症和神经病理学的长期影响中的作用
  • 批准号:
    10658408
  • 财政年份:
    2023
  • 资助金额:
    $ 25.46万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了